Cancer Australia supports cancer clinical trials in Australia in the following ways:
- Supports the 14 Multi-site Collaborative Cancer Clinical Trials Groups to develop investigator-initiated and industry-independent cancer clinical trials concepts and protocols.
- Funding National Technical Services to provide the trials groups with expert advice in health and pharmaco-economics, quality of life and genomics.
In 2024, over $22 million was awarded to support these groups until June 2027. The program contributes to the delivery of the Australian Cancer Plan through addressing unmet needs, improving trial design, and enhancing equitable access to cancer care, especially in rural and remote areas and Aboriginal and Torres Strait Islander communities.
Last updated 29 January 2025